Expression evaluation of in loco coagulation system in colorectal cancer;Ocena ekspresji in loco czynników układu krzepniȩcia krwi w raku jelita grubego

Polski Merkuriusz Lekarski

Volumn 18, Issue 104, 2005, Pages 176-179

  Sierko, Ewa ^a   Tokajuk, Piotr ^a   Butkiewicz, Adrianna ^a   Sulkowski, Stanisław ^a   Zimnoch, Lech ^a   Wojtukiewicz, Marek Z ^a  

^a AM ^*  (Poland)

Author keywords

Activation of coagulation; Coagulation factors; Colorectal cancer

Indexed keywords

BLOOD CLOTTING FACTOR; BLOOD CLOTTING FACTOR 10; BLOOD CLOTTING FACTOR 7; BLOOD CLOTTING FACTOR 9; FIBRINOGEN; PROTHROMBIN; THROMBOPLASTIN;

ADENOCARCINOMA; ADULT; AGED; ARTICLE; BLOOD CLOTTING; CANCER PATIENT; CLINICAL ARTICLE; COLORECTAL CANCER; DISEASE COURSE; FEMALE; HEMOSTASIS; HUMAN; IMMUNOHISTOCHEMISTRY; MALE; MALIGNANT NEOPLASTIC DISEASE; POLAND; PROTEIN EXPRESSION; STROMA CELL; THROMBOEMBOLISM; TUMOR ASSOCIATED LEUKOCYTE;

BLOOD COAGULATION; BLOOD COAGULATION FACTORS; CARCINOMA; COLORECTAL NEOPLASMS; FACTOR IXA; FACTOR VII; FACTOR X; FIBRIN; FIBRINOGEN; HUMANS; IMMUNOHISTOCHEMISTRY; NEOVASCULARIZATION, PATHOLOGIC; PROTHROMBIN; THROMBOPLASTIN;

EID: 14644392800     PISSN: 14269686     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (32)

1. Bromberg ME., Cappello M.: Cancer and blood coagulation: molecular aspects. Cancer J. Sci. Am., 1999, 5, 132-138.
2. Bromberg M.E. i wsp.: Tissue factor promotes metastasis by a pathway independent of blood coagulation. Proc. Natl. Acad. Sci., USA, 1995, 92, 8205-8209.
3. Camerer E. i wsp.: Coagulation factors VIIa and Xa induce cell signaling leading to up-regulation of the egr-1 gene. J. Biol. Chem., 1999, 274, 32225-32233.
4. Carty N. i wsp.: Urinary tissue factor activity in colorectal disease. Br. J. Surg., 1990, 77, 1091-1094.
5. Duijnhoven E.M. i wsp.: Evaluation of the coagulation/fibrinolysis balance in patients with colorectal cancer. Haemostasis, 1993, 23, 168-172.
6. Falanga A., Ricklers F.R.: Pathophysiology of the thrombophilic state in the cancer patient. Sem. Thromb. Hemost., 1999, 25, 173-182.
7. Folkman J., Shing Y.: Angiogenesis. J. Biol. Chem., 1992, 16, 10931-10934.
8. Folkman J.: Angiogenesis in cancer, vascular, rheumatoid and other diseases. Nat. Med., 1995, 1, 27-31.
9. Iversen L.H. i wsp.: Pre- and postoperative state of coagulation and fibrinolysis in plasma of patients with benign and malignant colorectal disease - a preliminary study. Thromb. Haemost., 1996, 76, 523-528.
10. Kataoka H. i wsp.: Analysis of tissue factor and tissue factor pathway inhibitor expression in human colorectal carcinoma cell lines and metastatic sublines to the liver. Int. J. Cancer, 1997, 72, 878-884.
11. Kudryk B. i wsp.: A monoclonal antibody for the NH2-terminal fragments derived from fibrinogen and fibrin. Molec. Immunol., 1984, 20, 1191-1200.
12. Lwaleed B.A. i wsp.: Urinary tissue factor levels in patients with breast and colorectal cancer. J. Pathol., 1999, 187, 291-294.
13. Modrau II. i wsp.: Hemostatic alterations in patients with benign and malignant colorectal disease during major abdominal surgery. Thromb. Res., 2000, 104, 309-315.
14. Mueller B.M. i wsp.: Requirement for binding of catalytically active factor VIIa in tissue factor dependent experimental metastasis. J. Clin. Invest., 1998, 101, 1372-1378.
15. Nowacki M.P. i wsp.: Nowotwory jelita grubego. W: Zasady rozpoznawania i leczenia nowotworów. Kułakowski A., Towpik E. (red.). Wydawnictwo Polskiej Fundacji Europejskiej Szkoły Onkologii.
16. Riewald M. i wsp.: Gene induction by coagulation factor Xa is mediated by activation of protease-activated receptor 1. Blood, 2001, 97, 3109-3116.
17. Rao L.V.M.: Tissue factor as a tumor procoagulant. Cancer Metast. Rev., 1992, 11, 249-266.
18. Sato Y. i wsp.: The AmeX method. The simplified technique of tissue processing and paraffin embedding with improved preservation of antigens for immunostaining. Am. J. Pathol., 1986, 125, 431-435.
19. Seto S. i wsp.: Tissue factor expression in human colorectal carcinoma. Cancer, 2000, 88, 295-301.
20. Shigemori C. i wsp.: Tissue factor expression and metastatic potential of colorectal cancer. Thromb. Haemost., 1998, 80, 894-898.
21. Sierko E. i wsp.: Czynniki układu hemostazy, a angiogeneza w nowotworach. Nowotwory, 2001, 51, 399-409.
22. Wojtukiewicz M.Z. i wsp.: Expression of prothtrombin fragment 1+2 in cancer tissue as an indicator of local activation of blood coagulation. Thromb. Res., 2000, 97, 335-342.
23. Wojtukiewicz M.Z. i wsp.: Expression of tissue factor and tissue factor pathway inhibitor in situ in laryngeal carcinoma. Thromb. Haemost., 1999, 82, 1659-1662.
24. Wojtukiewicz M.Z. i wsp.: Indirect activation of blood coagulation in colon cancer. Thromb. Haemost., 1989, 62, 1062-1066.
25. Wojtukiewicz M.Z. i wsp.: Low molecular weight heparin treatment for malignant melanoma, a pilot clinical trial. Thromb. Haemost., 2003, 89, 405-407.
26. Wojtukiewicz M.Z. i wsp.: Prognostic significance of blood coagulation tests in carcinoma of the lung and colon. Blood Coagul. Fibrinolysis, 1992, 3, 429-437.
27. Wojtukiewicz M.Z. i wsp.: Solid tumor express functional "tethered ligand" thrombin receptor. Cancer Res., 1995, 55, 698-704.
28. Wojtukiewicz M.Z. i wsp.: Zaburzenia hemostazy u chorych na nowotwory. W: Onkologia kliniczna. Krzakowski M. (red.). Wyd. Borgis, Warszawa 2001, 379-406.
29. Wojtukiewicz M.Z.: Zakrzepy a nowotwory. W: Zakrzepy i zatory. Łopaciuk S. (red.) Wyd. Lek. PZWL, Warszawa 2002, 105-124.
30. Wojtukiewicz M.Z. i wsp.: Aktywacja krzepniȩcia krwi u chorych na nowotwory, implikacje kliniczne. Nowotwory, 1999, 49, 381-391.
31. Wojtukiewicz M.Z. i wsp.: The hemostatic system and angiogenesis in malignancy. Neoplasia, 2001, 3, 371-384.
32. Wojtukiewicz M.Z. i wsp.: Localization of blood coagulation factors in situ in pancreatic carcinoma. Thromb. Haemost., 2001, 86, 1416-1420.